Chimeric antigen receptor T cell therapy (CAR-T cell therapy) is a new kind of immunotherapy with encouraging results in the treatment of hematological malignancies. At present, CD19 is the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback